| Literature DB >> 33663085 |
Yue Zhang1, Zuhua Gong, Sisi Chen.
Abstract
ABSTRACT: This study aims to investigate the effect of applying enhanced recovery after surgery methods (ERAS) in perioperative nursing of choledocholithiasis following endoscopic retrograde cholangiopancreatography (ERCP) for treatment of biliary calculus.Clinical data from 161 patients who underwent ERCP surgery in Wuhan Union Hospital from January 2017 to December 2019 were retrospectively analyzed. A total of 78 patients received perioperative nursing using the ERAS concept (experimental group) and 83 patients received conventional perioperative nursing (control group). Group differences were compared for the time to first postoperative ambulation, exhausting time, time to first defecation and eating, intraoperative blood loss, postoperative complication incidence (pancreatitis, cholangitis, hemorrhage), white blood cell (WBC), and serum amylase (AMS) values at 24 hours, duration of nasobiliary duct indwelling, length of hospital stay, and hospitalization expenses.No significant between-group differences were noted for demographic characteristics (age, sex, BMI, ASA score, and comorbidity) (P > .05). Time to first ambulation, exhausting time, time to defecation and eating, and nasobiliary drainage time were shorter in the experimental group than the control group, and the differences were statistically significant (P < .05). There was no significant between-group difference in postoperative WBC values at 24 hours (P > .05), but the experimental group's AMS values at 24 hours postoperation were significantly lower than those of the controls (154.93 ± 190.01 vs 241.97 ± 482.64, P = .031). Postoperative complications incidence was 9.1% in the experimental group, which was significantly lower than the 20.4% in the control group, and this difference was statistically significant (P = .039). Compared with the control group, nasobiliary drainage time (26.53 ± 7.43 hours vs 37.56 ± 9.91 hours, P < .001), hospital stay (8.32 ± 1.55 days vs 4.56 ± 1.38 days, P < .001), and hospitalization expenses (36800 ± 11900 Yuan vs 28900 ± 6500 Yuan, P = .016) were significantly lower in the experimental group.ERAS is a safe and effective perioperative nursing application in ERCP for treating choledocholithiasis. It can effectively accelerate patients' recovery and reduce the incidence of complications; therefore, it is worthy of being applied and promoted in clinical nursing.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33663085 PMCID: PMC7909146 DOI: 10.1097/MD.0000000000024730
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Demographic characteristics of patients.
| Characteristics | ERAS group (n = 78) n (%)/mean ± sd | Control group (n = 83) n (%)/mean ± sd | |
| Age (year) | 60.74 ± 17.85 | 63.49 ± 15.40 | .359 |
| Sex | .295 | ||
| Male | 37 (47.4) | 41 (49.4) | |
| Female | 41 (52.6) | 42 (50.6) | |
| BMI∗ | 22.5 ± 3.06 | 22.5 ± 2.77 | .697 |
| ASA∗ | .917 | ||
| II | 48 (61.5) | 56 (67.5) | |
| III | 27 (34.6) | 25 (30.1) | |
| IV | 3 (3.9) | 2 (2.4) | |
| Comorbidity | 11 (14.1) | 13 (15.7) | 0.797 |
| Hypertension | 5 (6.4) | 8 (9.6) | |
| Diabetes | 2 (2.6) | 2 (2.4) | |
| Coronary heart disease | 2 (2.6) | 4 (4.8) | |
| Cerebral infarction | 0 (0) | 1 (1.2) | |
| Schistosomiasis | 0 (0) | 2 (2.4) | |
| Cirrhosis | 0 (0) | 1 (1.2) | |
| Hypoalbuminemia | 2 (2.6) | 0 (0) | |
ASA = American Society of Anesthesiologists, BMI = body mass index.
3-D XB∗ represent 3-dimension x-ray beams, and EB∗ represent electron beams.
The comparison of related clinical indexes between the 2 groups.
| Characteristics | ERAS group (n = 78) n (%)/mean ± sd | Control group (n = 83) n (%)/mean ± sd | |
| The time to first ambulation (h) | 8.74 ± 4.85 | 16.35 ± 5.34 | .023 |
| Exhausting time (h) | 31.23 ± 5.20 | 51.30 ± 5.36 | <.001 |
| The time to first of defecation (h) | 48.31 ± 8.79 | 59.46 ± 7.54 | <.001 |
| The time to first of eating (h) | 32.00 ± 18.33 | 45.60 ± 30.34 | .001 |
| duration of nasobiliary drainage (h) | 26.53 ± 7.43 | 37.56 ± 9.91 | <.001 |
| Hospital stay (day) | 4.56 ± 1.38 | 8.32 ± 1.55 | <.001 |
| Hospitalization expenses (yuan) | 28900 ± 6500 | 36800 ± 11900 | .016 |
The comparison of intraoperative blooding loss and postoperative complications between the 2 groups.
| Characteristics | ERAS group (n = 78) n (%)/mean ± sd | Control group (n = 83) n (%)/mean ± sd | |
| Intraoperative blood loss (ml) | 4.65 ± 1.631 | 5.27 ± 2.553 | .359 |
| WBC | 6.47 ± 3.02 | 6.78 ± 4.23 | .511 |
| AMS | 154.93 ± 190.01 | 241.97 ± 482.64 | .031 |
| Total complications | 7 (9.1) | 17 (20.4) | .039 |
| Cholangitis | 1 (1.3) | 4 (4.8) | |
| Pancreatitis | 3 (3.9) | 7 (8.4) | |
| Postoperative hemorrhage | 0 (0) | 1 (1.2) | |
| Other | 3 (3.9) | 5 (6.0) |
WBC = white blood cell values 24 hours postoperative (4–10 × 109/L), AMS = Serum amylase postoperative values 24 hours postoperative (U/L).